Lite Strategy, Inc. announced financial results for the fiscal 2026 second quarter ended December 31, 2025, highlighting the launch of a covered call options program on its Litecoin holdings generating approximately $600,000 in gross premiums and initiation of a $25 million stock repurchase program. The company held $8.8 million in cash and cash equivalents as of December 31, 2025, and began pre-clinical R&D in pharmaceutical operations.
Key takeaways
Launched covered call options program generating approximately $600,000 in gross premiums during Q2 fiscal 2026
Commenced $25 million stock repurchase program using proceeds from treasury operations
Held $8.8 million in cash and cash equivalents as of December 31, 2025
Initiated pre-clinical research and development activities with drug candidate pipeline in non-oncology disease indications
Plans to continue share repurchase program and evaluate strategic investments or partnerships in second half of fiscal 2026